ALS Ltd (ASX: ALQ) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

ALS Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $10.94 billion
P/E Ratio 33.70
Dividend Yield 2.00%
Shares Outstanding 507.54 million
Earnings per share 0.630
Dividend per share 0.43
Year To Date Return -2.63%
Earnings Yield 2.97%
Franking 30
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • ALS Ltd (ASX: ALQ)
    Latest News

    Silhouettes of nine people climbing a steep mountain to the top at sunset, and helping each other along the way.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    It was a fairly grim day for ASX shares this Tuesday.

    Read more »

    A man clenches his fists in excitement as gold coins fall from the sky.
    Share Gainers

    Why ALS, OFX, Skycity, and TechnologyOne shares are surging today

    These shares are having a strong session on Tuesday. But why?

    Read more »

    A young smiling couple out hiking enjoy a view from the top of the mountains.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    It was a rough day for ASX investors this Tuesday.

    Read more »

    Two brokers analysing stocks.
    Broker Notes

    Leading brokers name 3 ASX shares to buy today

    Here's why brokers believe that now could be the time to snap up these shares.

    Read more »

    A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
    Share Fallers

    Why ALS, EOS, NRW, and Patriot Battery Metals are dropping today

    These ASX shares are starting the week in the red.

    Read more »

    The silhouettes of ten people holding hands with their arms raised against the sky, as the sun rises or sets in the background.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    It was a sobering finish to the trading week for ASX shares today.

    Read more »

    Smiling man working on his laptop.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    The ASX 200 staged a remarkable recovery this afternoon.

    Read more »

    Three people in a corporate office pour over a tablet, ready to invest.
    ASX Share Market News

    Insiders have been buying these 5 ASX All Ords shares

    Insiders appear to see value in these shares.

    Read more »

    A neon sign says 'Top Ten'.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    It was a mildly positive start to the trading week for ASX 200 shares this Monday.

    Read more »

    Hand with Australian dollar notes handing the money to another hand symbolising ex-dividend date.
    Dividend Investing

    5 ASX All Ords shares with ex dividend dates next week

    It won't be long until these companies pay their next dividends.

    Read more »

    A young female investor sits in her home office looking at her ipad and smiling as she sees the QBE share price rising
    Broker Notes

    Buy these 4 ASX 300 shares, say top brokers

    Market analysts have upgraded their ratings on these four ASX 300 shares today.

    Read more »

    Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
    ASX Share Market News

    Here are the top 10 ASX 200 shares today

    The ASX 200 was back to fine form this Tuesday...

    Read more »

    Frequently Asked Questions

    Yes, ALS Ltd historically pays two partially or fully franked dividends a year.

    ALS Ltd generally pays its shareholder dividends in July and December

    ALS Ltd listed on the ASX on 18 July 1952.

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    12 Jun 2026 $0.2310 30.00% Final 03 Jul 2026
    26 Nov 2025 $0.1940 29.90% Interim 17 Dec 2025
    03 Jul 2025 $0.1970 30.00% Final 25 Jul 2025
    27 Nov 2024 $0.1890 30.00% Interim 19 Dec 2024
    12 Jun 2024 $0.1960 20.00% Final 02 Jul 2024
    23 Nov 2023 $0.1960 20.00% Interim 14 Dec 2023
    09 Jun 2023 $0.1940 10.00% Final 06 Jul 2023
    24 Nov 2022 $0.2030 0.00% Interim 16 Dec 2022
    06 Jun 2022 $0.1700 30.00% Final 04 Jul 2022
    02 Dec 2021 $0.1580 30.00% Interim 17 Dec 2021
    07 Jun 2021 $0.1460 70.00% Final 05 Jul 2021
    26 Nov 2020 $0.0850 100.00% Interim 16 Dec 2020
    05 Jun 2020 $0.0610 70.00% Final 06 Jul 2020
    27 Nov 2019 $0.1150 30.00% Interim 16 Dec 2019
    03 Jun 2019 $0.1150 35.04% Final 01 Jul 2019
    29 Nov 2018 $0.1100 20.00% Interim 18 Dec 2018
    06 Jun 2018 $0.0900 40.00% Final 02 Jul 2018
    29 Nov 2017 $0.0800 40.00% Interim 18 Dec 2017
    07 Jun 2017 $0.0000 0.00% Final 03 Jul 2017
    05 Dec 2016 $0.0550 60.00% Interim 21 Dec 2016
    08 Jun 2016 $0.0600 40.00% Final 01 Jul 2016
    03 Dec 2015 $0.0750 25.07% Interim 18 Dec 2015
    11 Jun 2014 $0.2000 50.00% Final 02 Jul 2014
    07 Jun 2013 $0.2700 50.00% Final 02 Jul 2013
    05 Jun 2009 $0.4250 0.00% Final 01 Jul 2009
    01 Dec 2008 $0.4250 58.82% Interim 17 Dec 2008
    06 Jun 2008 $0.5100 58.82% Final 01 Jul 2008
    30 Nov 2007 $0.2975 58.82% Interim 17 Dec 2007
    06 Jun 2007 $0.3570 58.82% Final 02 Jul 2007
    29 Nov 2006 $0.2380 58.82% Interim 15 Dec 2006
    05 Jun 2006 $0.2900 100.00% Final 03 Jul 2006
    25 Nov 2005 $0.2100 100.00% Interim 20 Dec 2005
    04 Jun 2004 $0.1900 100.00% Final 01 Jul 2004
    28 Nov 2003 $0.1400 100.00% Interim 19 Dec 2003

    ALQ ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About ALS Ltd

    ALS Ltd (ASX: ALQ) is one of the world's largest laboratory testing, inspection, certification, and verification businesses. It operates from around 350 sites across 65 countries.

    Listed on the ASX in 1952, ALS operates two reportable divisions: Commodities and Life Sciences. ALS's Commodities segment traditionally generates the majority of the company's underlying earnings. It provides geochemistry, metallurgy, inspection, and mine site services for the mining industry globally.

    The company also provides environmental, pharmaceutical, and food and beverage testing and certification through its Life Sciences division. ALS Ltd has a multi-billion dollar market capitalisation and is part of the ASX 100.

    ALQ Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    04 Nov 2026 $20.82 $-0.41 -1.93% 1,052,654 $21.47 $21.47 $20.76
    03 Nov 2026 $21.23 $-0.01 -0.05% 793,009 $21.29 $21.65 $21.05
    02 Nov 2026 $21.24 $0.35 1.68% 1,175,128 $21.05 $21.42 $20.98
    30 Oct 2026 $20.89 $0.14 0.67% 1,294,856 $21.11 $21.15 $20.76
    29 Oct 2026 $20.75 $0.30 1.47% 580,945 $20.67 $20.80 $20.48
    28 Oct 2026 $20.45 $0.30 1.49% 1,242,089 $20.20 $20.62 $20.14
    27 Oct 2026 $20.15 $0.16 0.80% 2,584,715 $19.99 $20.24 $19.50
    26 Oct 2026 $19.99 $0.28 1.42% 3,000,826 $19.54 $20.22 $19.47
    23 Oct 2026 $19.71 $-0.66 -3.24% 3,217,204 $20.23 $20.31 $19.71
    22 Oct 2026 $20.37 $0.22 1.09% 1,093,372 $20.20 $20.55 $20.08
    21 Oct 2026 $20.15 $0.08 0.40% 886,446 $20.20 $20.20 $19.91
    20 Oct 2026 $20.07 $-0.12 -0.59% 1,100,730 $19.90 $20.16 $19.90
    19 Oct 2026 $20.19 $-0.06 -0.30% 1,237,621 $20.24 $20.28 $20.01
    16 Oct 2026 $20.25 $0.68 3.47% 2,757,231 $19.93 $20.43 $19.78
    15 Oct 2026 $19.57 $-0.54 -2.69% 1,798,998 $20.17 $20.17 $19.51
    14 Oct 2026 $20.11 $-0.23 -1.13% 1,124,630 $20.31 $20.35 $20.11
    13 Oct 2026 $20.34 $-0.28 -1.36% 2,039,598 $20.65 $20.65 $20.34
    12 Oct 2026 $20.62 $-0.01 -0.05% 608,960 $20.63 $20.73 $20.49
    09 Oct 2026 $20.63 $0.16 0.78% 863,014 $20.64 $20.66 $20.34
    08 Oct 2026 $20.47 $-0.62 -2.94% 1,287,849 $20.70 $20.94 $20.39
    07 Oct 2026 $21.09 $0.18 0.86% 879,512 $21.15 $21.17 $20.88
    06 Oct 2026 $20.91 $0.08 0.38% 1,230,589 $21.00 $21.06 $20.71

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    27 Aug 2026 Christina (Christy) Boyce Buy 2,000 $45,000
    On-market trade.
    21 Aug 2026 Christina (Christy) Boyce Buy 2,000 $43,600
    On-market trade.
    12 Aug 2026 Nigel Garrard Buy 2,454 $57,178
    On-market trade.
    30 Jul 2026 Malcom Deane Sell 60,944 $1,285,097
    On-market trade.
    28 Jul 2026 Malcom Deane Issued 123,270 $2,689,751
    Issue of securities. 474,485 Rights
    01 Jul 2026 Malcom Deane Expiry 49,181 $1,132,638
    As advised by the company. 468,509 rights, rights lapsed
    01 Jul 2026 Malcom Deane Exercise 145,177 $3,343,426
    Conversion of securities. 351,215 rights
    01 Jul 2026 Malcom Deane Issued 27,883 $642,145
    Issue of securities. 496,392 rights, per announcement
    01 Jul 2026 Malcom Deane Buy 145,177 $3,343,426
    Conversion of securities.
    29 May 2026 Catharine Farrow Buy 4,200 $100,425
    On-market trade.
    27 May 2026 Leslie Desjardins Buy 1,200 $28,300
    On-market trade.
    02 Dec 2025 Malcom Deane Sell 7,356 $161,317
    On-market trade. As per annouuncement on 05-12-2025

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Nigel David Garrard Non-Executive DirectorNon-Executive Chairman Jun 2023
    Mr Garrard is an executive with a track record across the fast-moving consumer goods and industrial/manufacturing sectors. He has over 20 years' experience as an ASX-listed CEO across three companies. In 2019, he retired as Managing Director and CEO of Orora Limited. He led the demerger of Orora Limited from Amcor, and the subsequent listing of Orora Limited on ASX in 2013. He was President of the Amcor Australasia and Packaging Distribution business group, Managing Director of Coca-Cola Amatil's Food and Services Division, and Managing Director of SPC Ardmona. Nigel brings international experience across listed, not-for-profit, government and private entities. He is currently the Chairman of Ansell Limited, Chairman of Flinders Port Holdings Pty Ltd, Chairman of the McMahon Services advisory board, and Director of Treasury Wine Estates Limited.
    Ms Christina (Christy) Boyce Non-Executive Director Sep 2025
    Ms Boyce has over 25 years' advisory experience in Australia and the United States, advising senior leadership across a range of industries including consumer and industrial goods, agribusiness and resources. Christy was a director (senior partner) of Port Jackson Partners. Prior to this, she was a partner at McKinsey & Co, working in the firm's Sydney, New York and Chicago offices. Throughout her career, Christy has worked with a range of growth companies focusing on strategy, organisational effectiveness and sales and marketing. Christy is currently a non-executive director of JB Hifi, BAI Communications Australia, EMM Consulting and a non-executive director of The Hunger Project Australia. She is a member of the Risk Committee, People Committee.
    Mrs Leslie A Desjardins Non-Executive Director Nov 2019
    Ms Desjardins has a background as a CFO and senior financial and governance professional in a range of multinational and global businesses. She has commercial and financial governance experience with multinational public companies in North America, Canada, and Australia each with global operations. Her areas of experience include CFO level executive and financial strategic leadership, M&A, corporate finance and treasury, governance, financial and tax compliance, and enterprise risk management. Leslie is currently a Director and Audit Committee member with Ansell Limited. During her executive career, Leslie served as Executive VP and CFO at Amcor Limited, a global leader in packaging of food, beverage, pharmaceutical and tobacco products. Prior to Amcor Ltd, Leslie served in financial and corporate strategic positions with General Motors Corporation, including Chief Financial Officer GM Holden Australia, Controller GM North America, Executive Director Manufacturing Finance and Director GM North America Strategy and Planning. She is the Chair of the Risk Committee, and a member of the People Committee.
    Dr Siddhartha Kadia Non-Executive Director Jan 2019
    Dr Kadia has lived and worked in the US, Japan, China, and India and has more than 25 years of international experience as a company director, executive and technical leader in the Life Sciences and TIC (testing, inspection and certification) sectors. Currently Siddhartha is CEO of Mesa Laboratories which commenced in April 2026. Siddhartha was formerly CEO and Director at Calibre Scientific, a privately held company that services life sciences tools industry and CEO of PhenomeX (Berkeley lights). In addition, he was President and CEO of EAG Laboratories, a global scientific testing company headquartered in San Diego, California. Prior to EAG, Siddhartha served as President of the Life Sciences Division at Life Technologies Corporation (NSDQ: LIFE), a publicly traded life sciences tools company. Siddhartha was also a management consultant at McKinsey & Company where his work focused on life sciences and healthcare related engagements. He is the Chair and a member of the Sustainability & Innovation Committee, and a member of the People Committee.
    Ms Erica Mann Non-Executive Director Mar 2024
    Ms Mann is a C-suite executive with a 30-year career across regulated, multi-channel and multi product environment in top DAX, NYSE, NASDAQ pharmaceutical, OTC and FMCG multinationals. Before retiring as an executive, Erica led Bayer's Consumer Health Division, one of the OTC companies. Prior to joining Bayer, she was President and General Manager of Pfizer Nutrition following its acquisition of Wyeth Inc, where she served as Senior Vice President of Global Nutrition. This followed other senior executive roles of other Fortune 500 companies including Eli Lily and Johnson & Johnson. She has held leadership positions in South Africa, Australia, New Zealand, Germany, Switzerland and the US. In addition to her executive experience in the nutrition and health industry, Erica has experience with global and emerging markets across Africa, China, Russia, and Brazil. Erica currently serves as an independent director of Kenvue and DSM-Firmenich. Erica was educated in South Africa and obtained diplomas in analytical chemistry (Tswane University, Pretoria), marketing management (IMM, Johannesburg), and small business development (SBDC -Johannesburg). She is a member of the Sustainability & Innovation Committee.
    Mr Peter Possemiers Non-Executive Director Nov 2022
    Mr Possemiers has a background as a TIC sector expert with almost 40 years' experience working as a senior executive in leadership roles globally for SGS. He has lead teams both regionally and globally most notably SGS's global Environment Health and Safety business, then a CHF 550 million business with a global headcount which exceeded 6000. As Executive Vice President, he was a member of the SGS Operations Council with responsibility for the strategic growth and profitability of the business, leading 15 strategic acquisitions. He is the Chair of the People Committee, and a member of the Risk Committee.
    Mr Malcom Deane Chief Strategy Officer General Manager Life Sciences - Food & Pharma Americas GeneralChief Executive OfficerManaging Director Mar 2023
    Mr Deane has served the company in leadership positions for the past 10 years in such roles as General Manager for Life Sciences Latin America, Food & Pharma Americas, and most recently as the Chief Strategy Officer, leading corporate strategy, business development and acquisitions.
    Ms Catharine Farrow Non-Executive Director Mar 2025
    Dr Farrow has more than 30 years of mining industry experience in all aspects of exploration, development, technical services, acquisitions, company building, operations, board governance and innovation/technology. Her experience ranges from the High Arctic to equatorial environments in base, critical and precious metals. Catharine also serves as a director of Franco-Nevada Corporation and is lead director of Aclara Resources Inc. She is a Member of the Board of Governors of Laurentian University. She is also in the mining and technology industries in both public and private companies, and academia as President of FarExGeoMine Ltd., where she provides advisory support in technical, governance, innovation and technology, organisational structure and as a witness. Catharine's executive career includes the role of Founding CEO and member of the Board of Directors of TMAC Resources Inc a public mining company based in Toronto. Previously she had been COO of KGHM International and held other executive roles in precursor companies from 2003 to 2012 including as Chief Technology Officer and Senior Vice President Corporate Development and Technical Services (including joint ventures, M&A opportunities, and strategy). She is a member of the Sustainability & Innovation Committee.
    Ms Dayna Field Company SecretaryGeneral Counsel Oct 2024
    -
    Stuart Hutton Chief Financial Officer
    -
    Dayna Field Company SecretaryGeneral Counsel
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Custody Nominees (Australia) Limited 161,719,043 31.86%
    J P Morgan Nominees Australia Pty Limited 82,964,814 16.35%
    Citicorp Nominees Pty Limited 82,631,353 16.28%
    BNP Paribas Noms Pty Ltd. 23,719,300 4.67%
    Citicorp Nominees Pty Limited <Colonial First State Inv A/C> 8,518,977 1.68%
    Faircase Pty Ltd. 8,452,085 1.67%
    BNP Paribas Nominees Pty Ltd <Agency Lending A/C> 5,836,951 1.15%
    Australian Foundation Investment Company Limited 5,540,000 1.09%
    Argo Investments Limited 5,050,000 1.00%
    BNP Paribas Nominees Pty Ltd <Hub24 Custodial Serv Ltd> 4,419,932 0.87%
    HSBC Custody Nominees (Australia) Limited <Nt Comnwlth Super Corp A/C> 4,175,914 0.82%
    WHSP Holdings Pty Limited 3,303,306 0.65%
    Buttonwood Nominees Pty Ltd 2,600,000 0.51%
    Netwealth Investments Limited <Wrap Services A/C> 2,274,650 0.45%
    Ms Maryon Catherine Campbell <The Checkmate A/C> 1,836,273 0.36%
    UBS Nominees Pty Ltd. 1,177,483 0.23%
    Mutual Trust Pty Ltd 1,128,569 0.22%
    BNP Paribas Noms (NZ) Ltd. 1,123,820 0.22%
    Certane CT Pty Ltd <ALS LTI A/C> 1,080,489 0.21%
    Merrill Lynch (Australia) Nominees Pty Ltd 1,058,225 0.21%

    Profile

    since

    Note